Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Shankar, Jay ^a   Nabi, Ivan R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN D; F ACTIN; JASPAMIDE; MESSENGER RNA; RHO A GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL 1; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACTIN FILAMENT; ARTICLE; CANCER CELL LINE; CELL SHAPE; CELL SIZE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DEPOLYMERIZATION; E CADHERIN GENE; ENZYME ACTIVATION; ENZYME INACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBROSARCOMA CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UPREGULATION; CELL MOTION; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; PHYSIOLOGY; PROTEIN MULTIMERIZATION; TUMOR CELL LINE;

ACTIN CYTOSKELETON; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMANS; NEOPLASM METASTASIS; PROTEIN MULTIMERIZATION; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84924371084     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119954     Document Type: Article

References (34)

1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454. PMID: 12189386
2. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428. doi: 10.1172/JCI39104 PMID: 19487818
3. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196. doi: 10.1038/nrm3758 PMID: 24556840
4. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, et al. Transforming growth fac-tor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12: 27-36. PMID: 11160820
5. Tavares AL, Mercado-Pimentel ME, Runyan RB, Kitten GT. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 2006; 235: 1589-1598. PMID: 16598712
6. Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 2007; 31: 1225-1230. PMID: 17537651
7. Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. Dynamic actin remodeling during epithelialmesenchymal transition depends on increased moesin expression. Mol Biol Cell 2011; 22: 4750-4764. doi: 10.1091/mbc.E11-02-0119 PMID: 22031288
8. Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 2012; 109: 1127-1132. doi: 10.1073/pnas.1111053108 PMID: 22210108
9. Tripathi V, Popescu NC, Zimonjic DB. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion. Oncogene 2014; 33: 724-733. doi: 10.1038/onc.2013. 7 PMID: 23376848
10. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 2001; 98: 6686-6691. PMID: 11390996
11. Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA, et al. Transforming growth factor betaregulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 2003; 5: R187-198. PMID: 14580254
12. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987-2002. PMID: 15689496
13. Keshamouni VG,Michailidis G, Grasso CS, Anthwal S, Strahler JR,Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006; 5: 1143-1154. PMID: 16674103
14. Liu J, Hu G, Chen D, Gong AY, Soori GS, Dobleman TJ, et al. Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis 2013; 2: e73. doi: 10.1038/ oncsis.2013.37 PMID: 24061576
15. Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT. In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet 2009; 41: 1133-1137. doi: 10.1038/ng.451 PMID: 19783987
16. Iwaya K, Norio K, Mukai K. Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma. Mod Pathol 2007; 20: 339-343. PMID: 17277766
17. Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, et al. Myosin II isoform switching mediates invasiveness after TGF-beta-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 2011; 108: 17991-17996. doi: 10.1073/pnas.1106499108 PMID: 22025714
18. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 2010; 70: 3780-3790. doi: 10.1158/0008-5472.CAN-09-4439 PMID: 20388789
19. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981. PMID: 16567498
20. Yook JI, Li X- Y, Ota I, Fearon ER, Weiss SJ. Wnt-dependent Regulation of the E-cadherin Repressor Snail. Journal of Biological Chemistry 2005; 280: 11740-11748. PMID: 15647282
21. Doherty GJ, McMahon HT. Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu Rev Biophys 2008; 37: 65-95. doi: 10.1146/annurev.biophys.37.032807.125912 PMID: 18573073
22. Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys 2011; 40: 169-186. doi: 10. 1146/annurev-biophys-042910-155359 PMID: 21314430
23. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33. doi: 10.1007/s10555-008-9169-0 PMID: 19169796
24. Stevenson BR, Begg DA. Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells. J Cell Sci 1994; 107 (Pt 3): 367-375. PMID: 8006058
25. Chen Y, Lu Q, Schneeberger EE, Goodenough DA. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 849-862. PMID: 10712504
26. Bosco D, Rouiller DG, Halban PA. Differential expression of E-cadherin at the surface of rat beta-cells as a marker of functional heterogeneity. J Endocrinol 2007; 194: 21-29. PMID: 17592017
27. Su HT, Weng CC, Hsiao PJ, Chen LH, Kuo TL, Chen YW, et al. Stem cell marker nestin is critical for TGF-beta1-mediated tumor progression in pancreatic cancer. Mol Cancer Res 2013; 11: 768-779. doi: 10.1158/1541-7786.MCR-12-0511 PMID: 23552743
28. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, Pena R, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 2008; 22: 756-769. doi: 10.1101/gad.455708 PMID: 18347095
29. Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000; 149: 775-782. PMID: 10811819
30. Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 2005; 65: 10938-10945. PMID: 16322241
31. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. Embo J 1999; 18: 578-585. PMID: 9927417
32. Gordon MC, David JN (2005) Developments and Future Trends in Anticancer Natural Products Drug Discovery. Anticancer Agents from Natural Products: CRC Press.
33. Newman DJ, Cragg GM. Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod 2004; 67: 1216-1238. PMID: 15332835
34. Huang FY, Mei WL, Li YN, Tan GH, Dai HF, Guo JL, et al. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models. Eur J Cancer 2012; 48: 2260-2269. doi: 10.1016/j. ejca.2011.12.018 PMID: 22257793